(Q35183975)

7 August 2017

1 reference

title

Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis (English)

1 reference

7 August 2017

0 references

0 references

0 references

Gerald D Silverberg

1

1 reference

7 August 2017

Martha Mayo

2

1 reference

7 August 2017

Thomas Saul

3

1 reference

7 August 2017

Edward Rubenstein

4

1 reference

7 August 2017

Dawn McGuire

5

1 reference

7 August 2017

publication date

1 August 2003

1 reference

7 August 2017

number of pages

6

1 reference

inferred from page(s)

published in

Lancet Neurology

1 reference

7 August 2017

volume

2

1 reference

7 August 2017

issue

8

1 reference

7 August 2017

page(s)

506-511

1 reference

Prevalence of Alzheimer's disease in patients investigated for presumed normal pressure hydrocephalus: a clinical and neuropathological study.

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Cerebrospinal fluid production is reduced in healthy aging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer's type.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Formation and absorption of cerebrospinal fluid in man

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

The production of cerebrospinal fluid in man and its modification by acetazolamide.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Cerebrospinal fluid production and dynamics in normal aging: a MRI phase-mapping study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Downregulation of cerebrospinal fluid production in patients with chronic hydrocephalus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Human choroid plexus: morphologic and histochemical alterations with age.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Ageing choroid plexus-cerebrospinal fluid system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Morphological alterations of the choroid plexus in late-onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Hydrocephalus decreases chloride efflux from the choroid plexus epithelium.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Relationship of senescence of cerebrospinal fluid circulatory system to dementias of the aged

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Can blood-brain barrier play a role in the development of cerebral amyloidosis and Alzheimer's disease pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Brain extracellular space and the sink action of cerebrospinal fluid. Measurement of rabbit brain extracellular space using sucrose labeled with carbon 14.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Use of long-term intracranial pressure measurement to assess hydrocephalic patients prior to shunt surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Is normal pressure hydrocephalus a valid concept in 2002? A reappraisal in five questions and proposal for a new designation of the syndrome as "chronic hydrocephalus".

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Age dependency of resistance to cerebrospinal fluid outflow.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Shunting effects in patients with idiopathic normal pressure hydrocephalus; correlation with cerebral and leptomeningeal biopsy findings

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Age dependence of cerebrospinal pressure-volume compensation in patients with hydrocephalus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Effect of spinal fluid pressure on cerebrospinal fluid formation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Midlife income, occupation, APOE status, and dementia: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Cerebrospinal fluid concentrations of soluble amyloid beta-protein and apolipoprotein E in patients with Alzheimer's disease: correlations with amyloid load in the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

alpha- and beta-secretase: profound changes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Amyloid beta-protein (A beta) accumulation in the leptomeninges during aging and in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Dutch Normal-Pressure Hydrocephalus Study: randomized comparison of low- and medium-pressure shunts.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Complications in ventricular cerebrospinal fluid shunting.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Seizures in Alzheimer's disease: clinicopathologic study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Myoclonus, seizures, and paratonia in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Cerebral hypoperfusion and delayed hippocampal response after induction of adult kaolin hydrocephalus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

White matter changes in normal pressure hydrocephalus and Binswanger disease: specificity, predictive value and correlations to axonal degeneration and demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Specific patterns of cognitive impairment in patients with idiopathic normal pressure hydrocephalus and Alzheimer's disease: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

A report of eight patients with low pressure hydrocephalus treated by C.S.F. diversion with disappointing results

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Cognitive recovery in idiopathic normal pressure hydrocephalus: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Shunting normal-pressure hydrocephalus: do the benefits outweigh the risks? A multicenter study and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Prognosis of dementia in normal-pressure hydrocephalus after a shunt operation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

Five-year outcome of normal pressure hydrocephalus with or without a shunt: predictive value of the clinical signs, neuropsychological evaluation and infusion test.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900487-3

7 January 2021

10.1016/S1474-4422(03)00487-3

Identifiers

DOI

1 reference

7 August 2017

1 reference